Omicron India

The World Health Organisation has classified the JN.1 variant as a 'variant of interest.' It is a descendant of the BA.2.86 variant (an Omicron sub-variant).

Over a year-and-a-half after India witnessed the Omicron wave, two eminent health experts have sounded a warning over the increasing Covid-19 cases in India in the wake of the JN.1 sub-variant of Omicron being detected in the country.

Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.

More than 1,300 samples of Omicron sub-variant XBB2.3 have been detected in India, while XBB.1.16 has become the dominant strain in the country, according to INSACOG data.

India recorded 12,591 news COVID-19 cases in the last 24 hours, 20 per cent higher than yesterday. Medical experts have said Omicron sub-variant XBB.1.16 could be driving the surge in cases.

India has logged 10,158 fresh Covid-19 cases over the past 24 hours. It is believed that the Omicron subvariant, XBB.1.16 is driving the latest surge in the country.

The omicron subvariant XBB.1.16 is the main cause of the surge. According to the WHO, the subvariant and its spread in India are being monitored.

Amid a spurt in fresh Covid infections, 234 cases of XBB1.16.1 mutated sub-variant have been found in the country, according to INSACOG data.

The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.

Symptoms of this variant include fever that gradually climbs and lasts for 1-2 days, sore throat, bodily soreness, headaches and abdominal discomfort.

Fever, sore throat, body pain, headaches and abdominal discomfort are some of the symptoms of the XBB.1.16 variant.

In the wake of rising COVID cases in India, Union Health Minister Mansukh Mandaviya on Monday said that Omicron's sub-variant which is circulating in the country has not led to the increase in hospitalisations and there is no need to worry.

The Union Health Ministry said on Thursday that the XBB.1.16 subvariant of Omicron might be the dominant virus strain in the country but there has been no reported increase in the rate of hospitalisation or death so far.

Omicron and its sub-lineages continue to be the dominant coronavirus variants in India, Minister of State for Health Bharati Pravin Pawar told the Lok Sabha on Friday.

Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.

The World Health Organisation has classified the JN.1 variant as a 'variant of interest.' It is a descendant of the BA.2.86 variant (an Omicron sub-variant).

Over a year-and-a-half after India witnessed the Omicron wave, two eminent health experts have sounded a warning over the increasing Covid-19 cases in India in the wake of the JN.1 sub-variant of Omicron being detected in the country.

Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.

More than 1,300 samples of Omicron sub-variant XBB2.3 have been detected in India, while XBB.1.16 has become the dominant strain in the country, according to INSACOG data.

India recorded 12,591 news COVID-19 cases in the last 24 hours, 20 per cent higher than yesterday. Medical experts have said Omicron sub-variant XBB.1.16 could be driving the surge in cases.

India has logged 10,158 fresh Covid-19 cases over the past 24 hours. It is believed that the Omicron subvariant, XBB.1.16 is driving the latest surge in the country.

The omicron subvariant XBB.1.16 is the main cause of the surge. According to the WHO, the subvariant and its spread in India are being monitored.

Amid a spurt in fresh Covid infections, 234 cases of XBB1.16.1 mutated sub-variant have been found in the country, according to INSACOG data.

The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.

Symptoms of this variant include fever that gradually climbs and lasts for 1-2 days, sore throat, bodily soreness, headaches and abdominal discomfort.

Fever, sore throat, body pain, headaches and abdominal discomfort are some of the symptoms of the XBB.1.16 variant.

In the wake of rising COVID cases in India, Union Health Minister Mansukh Mandaviya on Monday said that Omicron's sub-variant which is circulating in the country has not led to the increase in hospitalisations and there is no need to worry.

The Union Health Ministry said on Thursday that the XBB.1.16 subvariant of Omicron might be the dominant virus strain in the country but there has been no reported increase in the rate of hospitalisation or death so far.

Omicron and its sub-lineages continue to be the dominant coronavirus variants in India, Minister of State for Health Bharati Pravin Pawar told the Lok Sabha on Friday.

Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.